SPARC

SPARC signs pact with Bioprojet

Read more

SPARC enters into licensing deal with CMS to develop and commercialise products

Read more

SPARC gets orphan drug designation for Phenobarbital from US FDA

Read more

SPARC’s Rs 250-crore rights issue to open on March 28

Read more

US FDA reverses NDA nod for Sun Pharma’s anti epileptic drug

Read more

SPARC receives CRL from US FDA for Latanoprost NDA

Read more

SPARC licenses Xelpros to Sun Pharma

Read more